Geron stock opened at $1.64 on Wednesday. Geron has a 1-year low of $1.46 and a 1-year high of $5.34. The firm has a market capitalization of $1.04 billion, a price-to-earnings ratio of -5.13 and ...

SAN DIEGO, March 14, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Geron Corporation (NASDAQ ...

Geron Trading Down 1.8 % NASDAQ:GERN opened at $1.64 on Monday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 2.74 and a current ratio of 2.89. The firm has a market cap of $1. ...

Geron is also testing the drug for myelofibrosis (MF), another form of bone marrow cancer, and expects data from the phase 3 IMpactMF trial of imetelstat in relapsed/refractory MF in 2024.

Iran is using aerial drones, facial recognition systems, and a citizen-reporting app to enforce mandatory hijab laws on women, according to a United Nations report released Friday. The report ...

resulting in an inability for Geron to capitalize on the purportedly significant unmet need for the drug, particularly among first-line patients and those outside the academic setting. The ...

Geron's first-in-class cancer drug Rytelo, recently approved by the FDA for myelodysplastic syndromes (MDS), is priced three to four times higher than it should be, according to the Institute for ...

with Defense Secretary Pete Hegseth announcing that airstrikes will continue indefinitely until the Houthis cease their attacks on U.S. ships and drones. This escalation follows initial strikes that ...

Frightened by the prospect of US security disengagement and three years of Moscow's war against Ukraine, European countries are debating reinstating compulsory military service to boost their defences ...